Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy (2011)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; DALL'OGLIO, MARCOS FRANCISCO - FM
- Unidade: FM
- DOI: 10.1590/S1677-55382011000200004
- Subjects: NEFRECTOMIA; PROCEDIMENTOS CIRÚRGICOS UROLÓGICOS (MÉTODOS); NEOPLASIAS RENAIS; CÉLULAS DENDRÍTICAS; METÁSTASE NEOPLÁSICA
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2011
- Source:
- Título: International Brazilian Journal of Urology
- ISSN: 1677-5538
- Volume/Número/Paginação/Ano: v. 37, n. 2, p. 180-186, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DALL'OGLIO, Marcos F. et al. Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy. International Brazilian Journal of Urology, v. 37, n. 2, p. 180-186, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1677-55382011000200004. Acesso em: 14 fev. 2026. -
APA
Dall'Oglio, M. F., Sousa-Canavez, J. M., Tanno, F. Y., Tiseo, B. C., Crippa, A., Reis, S. T. dos, et al. (2011). Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy. International Brazilian Journal of Urology, 37( 2), 180-186. doi:10.1590/S1677-55382011000200004 -
NLM
Dall'Oglio MF, Sousa-Canavez JM, Tanno FY, Tiseo BC, Crippa A, Reis ST dos, Leite KRM, Srougi M. Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy [Internet]. International Brazilian Journal of Urology. 2011 ; 37( 2): 180-186.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1590/S1677-55382011000200004 -
Vancouver
Dall'Oglio MF, Sousa-Canavez JM, Tanno FY, Tiseo BC, Crippa A, Reis ST dos, Leite KRM, Srougi M. Early experience with targeted therapy and dendritic cell vaccine in metastatic renal cell carcinoma after nephrectomy [Internet]. International Brazilian Journal of Urology. 2011 ; 37( 2): 180-186.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1590/S1677-55382011000200004 - PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
- Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer
- Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?
- Robotic-assisted laparoscopic partial nephrectomy: initial experience in Brazil and a review of the literature
- Micro RNA expression in the development of prostate cancer. From prostatic intraepithelial neoplasia to metastases
- Expression profile of microrna-145 in urothelial bladder cancer
- Correlation between cell adhesion molecules expression and tumor outcome in prostate cancer
- Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma
- Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas
- Carbonic Anhydrase IX is Not a Predictor of Outcomes in Non-Metastatic Clear Cell Renal Cell Carcinoma - A Digital Analysis of Tissue Microarray
Informações sobre o DOI: 10.1590/S1677-55382011000200004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
